GlassScriptPhysician profile
Angelina E Meier
NPI 1316358500
$6,304.82
in general payments reported to CMS, 2019-2025
37 companies · $767 in 2025
The $767 reported for 2025 was more than what 81% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,088 · 2020: $308 · 2021: $431 · 2022: $955 · 2023: $1,924 · 2024: $831 · 2025: $767.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,523.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,522.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,208.60 | 2019-2025 | |
| Daiichi Sankyo INC. | $795.42 | 2019-2024 | Injectafer |
| Pfizer INC. | $650.16 | 2019-2025 | |
| Amgen INC. | $473.52 | 2019-2025 | Repatha, Otezla, Prolia |
| Lilly USA, LLC | $468.43 | 2019-2025 | Mounjaro, Zepbound, Trulicity |
| Novo Nordisk INC | $462.49 | 2019-2025 | Wegovy, Ozempic |
| Abbott Laboratories | $440.20 | 2019-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| Astellas Pharma US INC | $329.91 | 2019-2025 | Veozah, Myrbetriq |
| Glaxosmithkline, LLC. | $290.50 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Teva Pharmaceuticals USA, INC. | $143.35 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $140.91 | 2019-2024 | Farxiga, Airsupra |
| Exact Sciences Corporation | $110.58 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $87.87 | 2019-2024 | Xarelto |
| Nestle Healthcare Nutrition INC. | $85.25 | 2021-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $71.80 | 2022 |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angelina Meier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.